Changes in serum valproate and levetiracetam levels related to sex steroids in adolescent girls
Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2019Yazar
Şahin, SevimYılmaz, Semra Atasoy
Cansu, Ali
Kamasak, Tülay
Arslan, Elif Acar
Kaklikkaya, Neşe
Üst veri
Tüm öğe kaydını gösterKünye
Şahin, S., Yılmaz, S. A., Cansu, A., Kamaşak, T., Arslan, E. A., & Kaklıkkaya, N. (2019). Changes in Serum Valproate and Levetiracetam Levels Related to Sex Steroids in Adolescent Girls. Pediatric neurology, 96, 76–78. https://doi.org/10.1016/j.pediatrneurol.2019.03.010Özet
In girls with epilepsy, two problems arise after adolescence. First, valproate (VPA), a commonly used antiepileptic drug (AED) in childhood, has been associated with polycystic ovarian changes and reproductive endocrine disorders.1 Increased body weight with VPA has been suggested as a risk for polycystic ovary syndrome.